(Q82419635)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445969%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

A study to evaluate the use of CA125 in ovarian cancer follow-up: A change in practice led by patient preference (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445969%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445969%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Cheryl Palmer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445969%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jennie Pratt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445969%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Bristi Basu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445969%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

30 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445969%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445969%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445969%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445969%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

4-11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445969%20AND%20SRC:MED&resulttype=core&format=json

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

The CA 125 gene: an extracellular superstructure dominated by repeat sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

The CA 125 gene: a newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

Progress and challenges in screening for early detection of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

Risk of malignancy index in the preoperative evaluation of pelvic masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

Prognostic value of CA 125 in advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

Early serum CA125 response and outcome in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

Use of CA-125 response to predict survival parameters of patients with advanced ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: an analysis of 573 patients by the Medical Research Council Working Party on Gynaecological Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation☆

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

Cancer antigen 125 associated with multiple benign and malignant pathologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

In your skin you are different: women living with ovarian cancer during childbearing years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

Relapsed ovarian cancer: challenges and management strategies for a chronic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

CA125 response: can it replace the traditional response criteria in ovarian cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

Savings obtained by CA-125 measurements during therapy for ovarian carcinoma. The North Thames Ovary Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: a multivariate analysis of 704 patients [seecomments]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.046

10.1016/J.YGYNO.2005.11.046

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445969%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference